Showing results (1-10 of 111) with videos related to
Sort By:
Pageof 12
Molecular Biology International|July 11, 2012
HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of ActionsFrancesca Esposito, Angela Corona, Enzo TramontanoAntiviral Research|September 25, 2019
Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virusEnzo Tramontano, Angela Corona, Luis Menéndez-AriasAnnual Reports in Medicinal Chemistry|April 15, 2020
Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small MoleculesElisa Fanunza, Aldo Frau, Angela Corona, et al.Infectious Disorders Drug Targets|November 24, 2018
Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug TargetsElisa Fanunza, Aldo Frau, Angela Corona, et al.Peerj|October 27, 2015
Antityrosinase activity of Euphorbia characias extractsFrancesca Pintus, Delia Spanò, Angela Corona, et al.Chemotherapy|November 7, 2012
New anthraquinone derivatives as inhibitors of the HIV-1 reverse transcriptase-associated ribonuclease H functionFrancesca Esposito, Angela Corona, Luca Zinzula, et al.The Journal of Infectious Diseases|May 1, 2015
A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35-Associated Inhibition of Double-Stranded RNA-Stimulated, Retinoic Acid-Inducible Gene 1-Mediated Induction of Interferon βValeria Cannas, Gian Luca Daino, Angela Corona, et al.Antiviral Research|December 27, 2018
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS)Stuart Le Grice, Elias Maccioni, Angela Corona, et al.Viruses|March 3, 2018
Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN SignalingElisa Fanunza, Aldo Frau, Marco Sgarbanti, et al.Current Pharmaceutical Design|October 25, 2012
Molecular aspects of the RT/drug interactions. Perspective of dual inhibitorsSimona Distinto, Elias Maccioni, Rita Meleddu, et al.Pageof 12